XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -6.34%452.51M | -6.34%452.51M | 1.91%484.03M | 77.14%487.25M | 30.77%515.13M | 41.21%483.13M | 41.21%483.13M | 15.64%474.95M | -32.20%275.06M | -42.25%393.92M |
-Cash and cash equivalents | -6.34%452.51M | -6.34%452.51M | 1.91%484.03M | 77.14%487.25M | 30.77%515.13M | 41.21%483.13M | 41.21%483.13M | 15.64%474.95M | -32.20%275.06M | -42.25%393.92M |
Receivables | -1.85%35.24M | -1.85%35.24M | 16.66%39.72M | -13.66%35.14M | 6.21%35.05M | 27.19%35.91M | 27.19%35.91M | -49.54%34.05M | 227.39%40.69M | 274.00%33M |
-Accounts receivable | -1.85%35.24M | -1.85%35.24M | 16.66%39.72M | -13.66%35.14M | 6.21%35.05M | 27.19%35.91M | 27.19%35.91M | -49.54%34.05M | 227.39%40.69M | 274.00%33M |
Net loan | 16.41%3.51B | 16.41%3.51B | 15.74%3.42B | 9.65%3.32B | 12.15%3.2B | 15.75%3.02B | 15.75%3.02B | 18.70%2.96B | 29.20%3.03B | 48.11%2.85B |
-Gross loan | 17.64%3.7B | 17.64%3.7B | 17.43%3.6B | 10.50%3.48B | 13.49%3.35B | 16.92%3.14B | 16.92%3.14B | 19.88%3.07B | 31.10%3.15B | 49.54%2.95B |
-Allowance for loans and lease losses | 51.33%176.99M | 51.33%176.99M | 68.44%170.26M | 33.54%147.91M | 56.25%139.26M | 57.99%116.96M | 57.99%116.96M | 70.52%101.09M | 124.41%110.76M | 129.88%89.12M |
-Unearned income | 11.59%-6.45M | 11.59%-6.45M | 2.36%-7.21M | -15.41%-7.74M | -13.49%-7.46M | -19.53%-7.3M | -19.53%-7.3M | -11.71%-7.39M | -8.44%-6.71M | 2.79%-6.58M |
Securities and investments | -63.81%58.12M | -63.81%58.12M | -61.29%59.38M | -51.23%59.88M | -46.33%60.67M | 47.46%160.59M | 47.46%160.59M | 40.14%153.39M | 2.14%122.77M | -22.63%113.05M |
-Available for sale securities | 5.60%10.8M | 5.60%10.8M | -9.59%10.76M | -11.41%10.66M | -6.72%10.58M | -3.11%10.23M | -3.11%10.23M | 12.45%11.9M | 15.97%12.04M | 14.25%11.35M |
-Held to maturity securities | -7.03%47.29M | -7.03%47.29M | 14.18%48.58M | 291.42%49.17M | 1,250.85%50.05M | 4,809.27%50.86M | 4,809.27%50.86M | 3,304.00%42.55M | 896.27%12.56M | 188.10%3.71M |
-Short term investments | -99.96%35K | -99.96%35K | -99.96%38K | -99.96%39K | -99.96%41K | 2.25%99.5M | 2.25%99.5M | 1.35%98.94M | -9.57%98.17M | -27.35%98M |
Bank owned life insurance | 3.92%13.38M | 3.92%13.38M | 2.20%13.26M | 2.01%13.13M | 1.80%12.99M | 1.60%12.87M | 1.60%12.87M | 3.13%12.97M | 3.11%12.87M | 3.39%12.76M |
Net PPE | 16.52%32.65M | 16.52%32.65M | 17.21%31.26M | 20.07%30.16M | 25.87%28.75M | 20.62%28.02M | 20.62%28.02M | 12.24%26.67M | 3.65%25.12M | -4.71%22.84M |
-Gross PPE | -18.72%32.65M | -18.72%32.65M | 17.21%31.26M | 20.07%30.16M | 25.87%28.75M | 16.49%40.17M | 16.49%40.17M | 12.24%26.67M | 3.65%25.12M | -4.71%22.84M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -7.95%-12.15M | -7.95%-12.15M | ---- | ---- | ---- |
Other assets | 13.84%13.65M | 13.84%13.65M | -16.48%11.71M | 249.05%11.74M | 281.28%12.08M | 183.45%11.99M | 183.45%11.99M | 267.04%14.02M | -91.14%3.36M | -88.72%3.17M |
Total assets | 9.80%4.12B | 9.80%4.12B | 10.54%4.07B | 12.06%3.96B | 12.00%3.87B | 19.36%3.75B | 19.36%3.75B | 17.38%3.68B | 19.04%3.54B | 21.78%3.45B |
Liabilities | ||||||||||
Total deposits | 6.69%3.59B | 6.69%3.59B | 10.26%3.63B | 12.04%3.54B | 11.88%3.46B | 19.27%3.36B | 19.27%3.36B | 15.95%3.29B | 17.25%3.16B | 20.13%3.1B |
Payables | -12.77%30.13M | -12.77%30.13M | 2.48%40.26M | 24.77%35.54M | 7.86%34.16M | 63.69%34.54M | 63.69%34.54M | 25,576.47%39.29M | 8,530.30%28.48M | 21,153.69%31.67M |
-Accounts payable | -12.77%30.13M | -12.77%30.13M | 2.48%40.26M | 24.77%35.54M | 7.86%34.16M | 63.69%34.54M | 63.69%34.54M | 25,576.47%39.29M | 8,530.30%28.48M | 21,153.69%31.67M |
Long term debt and capital lease obligation | -1.07%53.28M | -1.07%53.28M | -1.04%53.46M | -0.81%53.63M | 2.04%53.72M | 1.96%53.86M | 1.96%53.86M | 61.51%54.02M | 60.46%54.07M | 55.07%52.64M |
-Long term debt | 0.31%47.88M | 0.31%47.88M | 0.32%47.85M | 0.32%47.81M | 0.32%47.77M | 0.31%47.73M | 0.31%47.73M | 70.76%47.7M | 70.75%47.66M | 70.72%47.62M |
-Long term capital lease obligation | -11.85%5.4M | -11.85%5.4M | -11.26%5.61M | -9.23%5.82M | 18.40%5.95M | 17.00%6.12M | 17.00%6.12M | 14.64%6.32M | 10.84%6.41M | -17.05%5.02M |
Employee benefits | -30.69%332K | -30.69%332K | -28.07%369K | -25.96%405K | -24.05%442K | -22.24%479K | -22.24%479K | -20.83%513K | -19.56%547K | -18.26%582K |
Other liabilities | 46.80%13.43M | 46.80%13.43M | 21.54%12.52M | -30.09%11.85M | -15.64%10.26M | 2.61%9.15M | 2.61%9.15M | -69.43%10.3M | -15.45%16.95M | -16.47%12.16M |
Total liabilities | 6.48%3.68B | 6.48%3.68B | 10.02%3.73B | 11.72%3.64B | 11.57%3.56B | 19.21%3.46B | 19.21%3.46B | 16.83%3.39B | 18.55%3.26B | 21.57%3.19B |
Shareholders'equity | ||||||||||
Share capital | 75.34%228.18M | 75.34%228.18M | 4.27%134.77M | 3.64%132.99M | 3.26%131.6M | 3.42%130.14M | 3.42%130.14M | 4.28%129.24M | 4.13%128.32M | 3.96%127.45M |
-common stock | 75.34%228.18M | 75.34%228.18M | 4.27%134.77M | 3.64%132.99M | 3.26%131.6M | 3.42%130.14M | 3.42%130.14M | 4.28%129.24M | 4.13%128.32M | 3.96%127.45M |
-Preferred stock | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 27.35%210.53M | 27.35%210.53M | 26.14%197.16M | 25.80%183.71M | 29.29%172.11M | 37.76%165.31M | 37.76%165.31M | 46.24%156.3M | 52.46%146.03M | 55.51%133.12M |
Gains losses not affecting retained earnings | 99.57%-2K | 99.57%-2K | 99.91%-1K | 99.88%-2K | 99.89%-2K | 79.91%-469K | 79.91%-469K | 47.73%-1.09M | -25.15%-1.68M | -557.09%-1.81M |
Total stockholders'equity | 48.72%438.7M | 48.72%438.7M | 16.69%331.93M | 16.15%316.69M | 17.37%303.71M | 21.14%294.98M | 21.14%294.98M | 24.36%284.45M | 25.27%272.66M | 24.45%258.76M |
Total equity | 48.72%438.7M | 48.72%438.7M | 16.69%331.93M | 16.15%316.69M | 17.37%303.71M | 21.14%294.98M | 21.14%294.98M | 24.36%284.45M | 25.27%272.66M | 24.45%258.76M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |